
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[BEAM] Beam Therapeutics Inc - Investing Cash Flow / Sales
Data updated 2024-Mar-09 (Saturday)Note: Detailed Statistics for Investing Cash Flow / Sales in Cashflow Statement for Beam Therapeutics Inc [NASDAQ:BEAM] with frequency distribution chart that analyze trends & history . Investing Cash Flow / Sales or Revenue is expressed as a % for period. View Cashflow Statement for broader context
Share
Quarterly Investing Cash Flow / Sales values for Beam Therapeutics Inc are rounded to enhance readability
2023-Dec | 2023-Sep | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | |
---|---|---|---|---|---|---|
Investing Cash Flow / Sales | 22.7% | -59.5% | -206.2% | 105.1% | 566.2% | -229.0% |
Sequential Quarter Growth | +138.2% | +71.1% | -296.1% | -81.4% | +347.3% | -2,920.6% |
Quarter-on Quarter Growth | -96.0% | +74.0% | -2,620.3% | +101.7% | +473.1% | -102.3% |
Annual Investing Cash Flow / Sales values for Beam Therapeutics Inc are rounded to enhance readability
2023-Dec | 2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | |
---|---|---|---|---|---|---|
Investing Cash Flow / Sales | 19.0% | -757.3% | -482.8% | -193.1% | -277,745.8% | -74,577.8% |
Year-on-Year Growth | +102.5% | -56.8% | -150.0% | +99.9% | -272.4% | |
2-yr CAGR | ||||||
3-yr CAGR | ||||||
4-yr CAGR | ||||||
5-yr CAGR |
Frequency distribution of quarterly Investing Cash Flow / Sales values from 2019-Mar-31 grouped into buckets. Latest Investing Cash Flow / Sales value is 22.7 as of 2023-Dec-31
Subsequent stock performance post earnings date till next announcement for Beam Therapeutics Inc mapped with quarterly Investing Cash Flow / Sales values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Investing Cash Flow / Sales above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Beam Therapeutics Inc with subsequent post-earnings performance given Investing Cash Flow / Sales values. Analysis uses quarterly data and subsequent relative performance benchmarked to S&P 500 index. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (relative perf.) | Outperform (relative perf.) | |
---|---|---|
Investing Cash Flow / Sales - Low | 50% | 50% |
Investing Cash Flow / Sales - Medium | 60% | 40% |
Investing Cash Flow / Sales - High | 40% | 60% |
Investing Cash Flow / Sales (Sequential growth %) - Low | 50% | 50% |
Investing Cash Flow / Sales (Sequential growth %) - Medium | 80% | 20% |
Investing Cash Flow / Sales (Sequential growth %) - High | 20% | 80% |
Investing Cash Flow / Sales (QoQ growth %) - Low | 80% | 20% |
Investing Cash Flow / Sales (QoQ growth %) - Medium | 80% | 20% |
Investing Cash Flow / Sales (QoQ growth %) - High | 0% | 100% |
Related to Beam Therapeutics Inc
Information for Beam Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-16 on Google
SEC Reports : Quarterly reports around 2025-May-16 on SEC Edgar
Compare Beam Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Beam Therapeutics Inc
Industry : Biotechnology industry performance which includes Beam Therapeutics Inc